FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christoph Wanner

Research Profile

Procedures

Renal Dialysis

Disorders

Chemicals & Drugs

Concepts & Ideas

Risk Factors

Anatomy

Physiology

Glomerular Filtration Rate

Living Beings

Rats

Co-author Network

Publications

TOP 3
Christoph Wanner; Kitty J Jager
Cardiovascular disease: Is CABG really better than PCI in dialysis patients?
Anders H Berg; Roberto Buccafusca; John Danziger; Christiane Drechsler; David J Friedman; Tammy Hod; Sahir Kalim; Samir M Parikh; Wenda Ramma; Hanno Steen; Ravi Thadhani; Christoph Wanner; Julia Wenger; S Ananth Karumanchi
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.
Detlef H Krieter; Horst-Dieter Lemke; Andreas Morgenroth; Annie Rodriguez; Kai von Appen; Bernard CANAUD; Gerd-Peter Dragoun; Christoph Wanner
Bisphenol A in chronic kidney disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christoph Wanner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christoph Wanner; Kitty J Jager
Cardiovascular disease: Is CABG really better than PCI in dialysis patients?
Nature reviews. Nephrology 2013;9(4):197-8.
2013: Anders H Berg; Roberto Buccafusca; John Danziger; Christiane Drechsler; David J Friedman; Tammy Hod; Sahir Kalim; Samir M Parikh; Wenda Ramma; Hanno Steen; Ravi Thadhani; Christoph Wanner; Julia Wenger; S Ananth Karumanchi
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.
Science translational medicine 2013;5(175):175ra29.
2013: Detlef H Krieter; Horst-Dieter Lemke; Andreas Morgenroth; Annie Rodriguez; Kai von Appen; Bernard CANAUD; Gerd-Peter Dragoun; Christoph Wanner
Bisphenol A in chronic kidney disease.
Artificial organs 2013;37(3):283-90.
2013: Christiane Drechsler; Martin Fassnacht; Fabian Hammer; Vera Krane; Winfried März; Stefan Pilz; Eberhard Ritz; Stephan Schönfeld; Andreas Tomaschitz; Bruno Allolio; Martin Bidlingmaier; Katja Blouin; Christoph Wanner
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.
European heart journal 2013;34(8):578-87.
2013: Christiane Drechsler; Barbara Kollerits; Paul König; Florian Kronenberg; Winfried März; Andreas Meinitzer; Ulrich Neyer; Stefan Pilz; Eberhard Ritz; Christoph Wanner
Homoarginine and progression of chronic kidney disease: results from the mild to moderate kidney disease study.
PloS one 2013;8(5):e63560.
2013: Andreas Schneider; Markus P Schneider; Christoph Wanner; Alan G Jardine; Hubert Scharnagl; Christiane Drechsler
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes.
BMC nephrology 2013;14():67.
2013: Markus Niemann; Arndt Rolfs; Christoph Wanner; Frank Breunig; Georg Ertl; Anne Giese; Hermann Mascher; Frank Weidemann
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease.
JIMD reports 2013;7():99-102.
2013: Claudia Sommer; Nurcan Üçeyler; Christoph Wanner; K Arning; R Baron; E Brand; S Canaan-Kühl; Thomas Duning; M Hilz; D Naleschinski; Frank Weidemann
[Pain therapy for Fabry's disease].
Der Internist 2013;54(1):121-2, 124-30.
2012: Hector Tamez; B Taylor Thompson; Christoph Wanner; Julia Wenger; Daniel Zehnder; Wuyan Zhang; Carmine Zoccali; Rajiv Agarwal; Dennis Andress; Evan Appelbaum; Ishir Bhan; Jorge Cannata; Yuchiao Chang; Donald Lloyd-Jones; Warren J Manning; Ajay Pachika; David Packham; Yili Pritchett; Amil Shah; Bhupinder Singh; Scott D Solomon; Ravi Thadhani
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.
American heart journal 2012;164(6):902-9.e2.
2012: B Petritsch; Christoph Wanner; Frank Weidemann; A M Weng; J P Goltz; Dietbert Hahn; M Horn; Herbert Köstler; Wolfram Machann; Markus Niemann; Meinrad Beer
Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopy.
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2012;184(11):1020-5.
2012: Sabrina Koeppe; Herbert Köstler; Wolfram Machann; Henning Neubauer; Jörn Sandstede; Christoph Wanner; Frank Weidemann; Frank Breunig; Dietbert Hahn; Meinrad Beer
MR-based analysis of regional cardiac function in relation to cellular integrity in Fabry disease.
International journal of cardiology 2012;160(1):53-8.
2012: Karl Winkler; Christiane Drechsler; Michael M Hoffmann; Vera Krane; Christoph Wanner
Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis.
European journal of clinical investigation 2012;42(7):693-701.
2012: Frank Weidemann; Meinrad Beer; Frank Breunig; Markus Niemann; Claudia Sommer; Christoph Wanner
Interdisciplinary approach towards female patients with Fabry disease.
European journal of clinical investigation 2012;42(4):455-62.
2012: David G Warnock; Dana Beitner-Johnson; J Alexander Cole; Dominique P Germain; Roberta Lemay; Gabor E Linthorst; László Maródi; Michael Mauer; Renzo Mignani; João P Oliveira; Alberto Ortiz; Andreas L Serra; Einar Svarstad; Bojan Vujkovac; Stephen Waldek; Christoph Wanner
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(3):1042-9.
2012: Ravi Thadhani; B Taylor Thompson; Christoph Wanner; Julia Wenger; Daniel Zehnder; Wuyan Zhang; Carmine Zoccali; Hector Tamez; Rajiv Agarwal; Dennis Andress; Evan Appelbaum; Ishir Bhan; Jorge Cannata; Yuchiao Chang; Donald Lloyd-Jones; Warren J Manning; Ajay Pachika; David Packham; Yili Pritchett; Amil Shah; Bhupinder Singh; Scott D Solomon
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
JAMA : the journal of the American Medical Association 2012;307(7):674-84.
2012: Theresa Reiter; Oliver Ritter; Christoph Wanner; Eike Nagel; Peter Nordbeck; Martin R Prince; Wolfgang R Bauer
Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2012;14():31.
2012: Boris Betz; Tobias Kress; Martin Alexander Schick; Reinhard Schneider; Christoph Wanner; Christoph Sauvant
Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury.
PPAR research 2012;2012():219319.
2012: Andreas Schneider; Markus P Schneider; Christoph Wanner; Christiane Drechsler; Vera Krane; Detlef H Krieter; Hubert Scharnagl
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(1):52-9.
2011: Michael M Hoffmann; Winfried März; Christiane Drechsler; Bernd Genser; Christoph Wanner
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D study.
Atherosclerosis 2011;219(2):659-62.
2011: W Wuest; Frank Breunig; Dietbert Hahn; H Koestler; Wolfram Machann; Christoph Wanner; Frank Weidemann; Meinrad Beer
Right ventricular involvement in patients with Fabry's disease and the effect of enzyme replacement therapy.
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2011;183(11):1037-42.
2011: R Schneider; Christoph Wanner; B Betz; M Kersten; H Koepsell; M Meusel; K Möller-Ehrlich; Christoph Sauvant
Nitric oxide-induced regulation of renal organic cation transport after renal ischemia-reperfusion injury.
American journal of physiology. Renal physiology 2011;301(5):F997-F1004.
2011: Christiane Drechsler; Diana C Grootendorst; Vera Krane; Winfried März; Stefan Pilz; Eberhard Ritz; Andreas Tomaschitz; Friedo Dekker; Christoph Wanner
Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;58(4):599-607.
2011: Markus Niemann; Toshihiro Takenaka; Chuwa Tei; Christoph Wanner; Meinrad Beer; Frank Breunig; Andrea Emmert; Georg Ertl; Sebastian Herrmann; Kai Hu; Dan Liu; Frank Weidemann
Tei index in fabry disease.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2011;24(9):1026-32.
2011: Christiane Drechsler; Vera Krane; Winfried März; Andreas Meinitzer; Stefan Pilz; Eberhard Ritz; Andreas Tomaschitz; Christoph Wanner
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.
European journal of heart failure 2011;13(8):852-9.
2011: Stefan Pilz; Eberhard Ritz; Andreas Tomaschitz; Christoph Wanner; Bernhard O Boehm; Christiane Drechsler; Vera Krane; Andreas Meinitzer; Winfried März
Low homoarginine concentration is a novel risk factor for heart disease.
Heart (British Cardiac Society) 2011;97(15):1222-7.
2011: Martin Wagner; Christoph Wanner; Josef Zimmermann; Ahsan Alam; Angelika Koljaja-Batzner; Ulrike Raff; Katharina Rauh; Lothar Schramm
Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(7):1573-9.
2011: Christoph Wanner; Vera Krane
Sunrise of statins after AURORA and 4D?
Journal of the American Society of Nephrology : JASN 2011;22(7):1184-6.
2011: Vera Krane; Christoph Wanner
Statins, inflammation and kidney disease.
Nature reviews. Nephrology 2011;7(7):385-97.
2011: Markus Niemann; Jörg Strotmann; Wolfram Voelker; Christoph Wanner; Meinrad Beer; Frank Breunig; Georg Ertl; Sebastian Herrmann; Kai Hu; Wolfram Machann; Frank Weidemann
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
JACC. Cardiovascular imaging 2011;4(6):592-601.
2011: Martin Wagner; David Ansell; david kent; John L Griffith; David M J Naimark; Christoph Wanner; Navdeep Tangri
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;57(6):894-902.
2011: Wiebke Fenske; Christoph Wanner; Bruno Allolio; Christiane Drechsler; Katja Blouin; Jürgen Lilienthal; Vera Krane
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.
Journal of the American Society of Nephrology : JASN 2011;22(4):782-90.
2011: Stefan Pilz; Andreas Tomaschitz; Andreas Meinitzer; Christiane Drechsler; Eberhard Ritz; Vera Krane; Christoph Wanner; Bernhard O Böhm; Winfried März
Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography.
Stroke; a journal of cerebral circulation 2011;42(4):1132-4.
2011: Wolfram Machann; Frank Breunig; Frank Weidemann; Jörn Sandstede; Dietbert Hahn; Herbert Köstler; Stefan Neubauer; Christoph Wanner; Meinrad Beer
Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase A.
European journal of heart failure 2011;13(3):278-83.
2011: Christoph Wanner; Vera Krane
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
Kidney & blood pressure research 2011;34(4):209-17.
2011: Ravi Thadhani; Evan Appelbaum; Yuchiao Chang; Yili Pritchett; Ishir Bhan; Rajiv Agarwal; Carmine Zoccali; Christoph Wanner; Donald Lloyd-Jones; Jorge Cannata; Taylor Thompson; Paul Audhya; Dennis Andress; Wuyan Zhang; Jun Ye; David Packham; Bhupinder Singh; Daniel Zehnder; Warren J Manning; Ajay Pachika; Scott D Solomon
Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease.
American journal of nephrology 2011;33(2):139-49.
2011: Gabor E Linthorst; Dominique P Germain; Carla E M Hollak; derralynn hughes; Arndt Rolfs; Christoph Wanner; Atul Mehta
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT).
Molecular genetics and metabolism 2011;102(1):99-102.
2011: Frank Weidemann; Markus Niemann; David G Warnock; Georg Ertl; Christoph Wanner
The Fabry cardiomyopathy: models for the cardiologist.
Annual review of medicine 2011;62():59-67.
2011: Markus Niemann; Dan Liu; Kai Hu; Sebastian Herrmann; Frank Breunig; Jörg Strotmann; Stefan Störk OR Stoerk; Wolfram Voelker; Georg Ertl; Christoph Wanner; Frank Weidemann
Prominent papillary muscles in Fabry disease: a diagnostic marker?
Ultrasound in medicine & biology 2011;37(1):37-43.
2010: Christoph Wanner; João P Oliveira; Alberto Ortiz; Michael Mauer; Dominique P Germain; Gabor E Linthorst; Andreas L Serra; László Maródi; Renzo Mignani; Bruno Cianciaruso; Bojan Vujkovac; Roberta Lemay; Dana Beitner-Johnson; Stephen Waldek; David G Warnock
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(12):2220-8.
2010: Winfried März; Andreas Meinitzer; Christiane Drechsler; Stefan Pilz; Vera Krane; Marcus E Kleber; Joachim Fischer; Bernhard R Winkelmann; Bernhard O Böhm; Eberhard Ritz; Christoph Wanner
Homoarginine, cardiovascular risk, and mortality.
Circulation 2010;122(10):967-75.
2010: Frank Weidemann; Markus Niemann; Claudia Sommer; Meinrad Beer; Frank Breunig; Christoph Wanner
[Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge].
Medizinische Klinik (Munich, Germany : 1983) 2010;105(9):627-34.
2010: Christiane Drechsler; Stefan Pilz; Barbara Obermayer-Pietsch; Marion Verduijn; Andreas Tomaschitz; Vera Krane; Katharina Espe; Friedo Dekker; Vincent Brandenburg; Winfried März; Eberhard Ritz; Christoph Wanner
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients.
European heart journal 2010;31(18):2253-61.
2010: Gerd Walz; Klemens Budde; Marwan Mannaa; Jens Nürnberger; Christoph Wanner; Claudia Sommerer; Ulrich Kunzendorf; Bernhard Banas; Walter H Hörl; Nicholas Obermüller; Wolfgang Arns; Hermann Pavenstädt; Jens Gaedeke; Martin Büchert; Christoph May; Harald Gschaidmeier; Stefan Kramer; Kai-Uwe Eckardt
Everolimus in patients with autosomal dominant polycystic kidney disease.
The New England journal of medicine 2010;363(9):830-40.
2010: Eberhard Ritz; Christoph Wanner
Statins: do we definitely know whether they are completely inefficacious in ESRD?
Kidney international 2010;78(1):111-2; author reply 112.
2010: Vera Krane; Mario Berger; Jürgen Lilienthal; Karl Winkler; Christian Schambeck; Christoph Wanner
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(5):874-81.
2010: Kai Lopau; Christoph Wanner
Hypertension after kidney transplantation: still a SECRET?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(3):664-5.
2010: David G Warnock; Giuseppe Remuzzi; Barry M Brenner; Adeera Levin; Christoph Wanner
Introduction to Focus on Fabry nephropathy: biomarkers, progression, and disease severity.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(2):359.
2010: Christoph Sauvant; R Schneider; Hildegard Holzinger; S Renker; Christoph Wanner; Michael Gekle
Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model.
American journal of nephrology 2010;32(1):57-65.
2010: Kai Lopau; Karin Syamken; Peter Rubenwolf; Hubertus Riedmiller; Christoph Wanner
Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation.
Kidney & blood pressure research 2010;33(1):52-9.
2010: Christina Zuern; Jutta Heimrich; Roland Kaufmann; Konrad K Richter; Utz Settmacher; Christoph Wanner; Jan Galle; Stefan Seibold
Down-regulation of MTUS1 in human colon tumors.
Oncology reports 2010;23(1):183-9.
2010: Detlef H Krieter; Andrea Hackl; Annie Rodriguez; Leïla Chenine; Hélène Leray Moragues; Horst-Dieter Lemke; Christoph Wanner; Bernard CANAUD
Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(1):212-8.
2010: Karl Winkler; Michael M Hoffmann; Vera Krane; Winfried März; Christiane Drechsler; Christoph Wanner
Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus.
Atherosclerosis 2010;208(1):197-202.
2009: Christiane Drechsler; Vera Krane; Eberhard Ritz; Winfried März; Christoph Wanner
Glycemic control and cardiovascular events in diabetic hemodialysis patients.
Circulation 2009;120(24):2421-8.
2009: R Schneider; M Meusel; S Renker; C Bauer; H Holzinger; M Roeder; Christoph Wanner; M Gekle; C Sauvant
Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome.
American journal of physiology. Renal physiology 2009;297(6):F1614-21.
2009: Gülmisal Güder; Stefan Frantz; Johann Bauersachs; Bruno Allolio; Christoph Wanner; Michael Koller; Georg Ertl; Christiane E Angermann; Stefan Störk OR Stoerk
Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
Circulation. Heart failure 2009;2(6):563-71.
2009: Vera Krane; Karl Winkler; Christiane Drechsler; Jürgen Lilienthal; Winfried März; Christoph Wanner
Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(5):902-11.
2009: Christiane Drechsler; Vera Krane; Diana C Grootendorst; Eberhard Ritz; Karl Winkler; Winfried März; Friedo W Dekker; Christoph Wanner
The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(10):3151-7.
2009: Susanne B Schwedler; Thomas Hansen-Hagge; Matthias Reichert; Daniel Schmiedeke; Reinhard Schneider; Jan Galle; Lawrence Potempa; Christoph Wanner; János G Filep
Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells.
Clinical chemistry 2009;55(9):1728-31.
2009: Christiane Drechsler; Vera Krane; Karl Winkler; Friedo W Dekker; Christoph Wanner
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients.
Kidney international 2009;76(5):567-75.
2009: Christoph Wanner; Christiane Drechsler; Vera Krane
C-reactive protein and uremia.
Seminars in dialysis 2009;22(4):438-41.
2009: Frank Weidemann; Markus Niemann; Frank Breunig; Sebastian Herrmann; Meinrad Beer; Stefan Störk OR Stoerk; Wolfram Voelker; Georg Ertl; Christoph Wanner; Jörg Strotmann
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
Circulation 2009;119(4):524-9.
2009: Vera Krane; Fritz Heinrich; Malte Meesmann; Manfred Olschewski; Jürgen Lilienthal; Christiane Angermann; Stefan Störk OR Stoerk; Johann Bauersachs; Christoph Wanner; Stefan Frantz
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(2):394-400.
2009: Frank Weidemann; Claudia Sommer; Thomas Duning; Ines Lanzl; Matthias Möhrenschlager; Dennis Naleschinski; Ralf Baron; Frank Breunig; Roland Schaefer; Jörg Strotmann; Christoph Wanner
[Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge].
Medizinische Klinik (Munich, Germany : 1983) 2009;104(1):10-9.
2009: Christoph Sauvant; Reinhard Schneider; Hildegard Holzinger; Sylvia Renker; Christoph Wanner; Michael Gekle
Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009;24(5-6):567-76.
2009: Christoph Wanner
Prevention of cardiovascular disease in chronic kidney disease patients.
Seminars in nephrology 2009;29(1):24-9.
2008: Detlef H Krieter; Elisabeth Hunn; Andreas Morgenroth; Horst-Dieter Lemke; Christoph Wanner
Matching efficacy of online hemodiafiltration in simple hemodialysis mode.
Artificial organs 2008;32(12):903-9.
2008: Christoph Wanner; Eberhard Ritz
Reducing lipids for CV protection in CKD patients-current evidence.
Kidney international. Supplement 2008;(111):S24-8.
2008: Frank Weidemann; Christoph Wanner; Frank Breunig
Nomen est omen. Fabry disease.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2008;9(6):831-2.
2008: Karl Winkler; Christoph Wanner; Christiane Drechsler; Jürgen Lilienthal; Winfried März; Vera Krane
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.
European heart journal 2008;29(17):2092-9.
2008: Detlef H Krieter; Horst-Dieter Lemke; Christoph Wanner
A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Artificial organs 2008;32(7):547-54.
2008: Eberhard Ritz; Christoph Wanner
Lipid abnormalities and cardiovascular risk in renal disease.
Journal of the American Society of Nephrology : JASN 2008;19(6):1065-70.
2008: Eberhard Ritz; Christoph Wanner
The challenge of sudden death in dialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(3):920-9.
2008: Thomas E Hansen-Hagge; Elke Baumeister; Tanja Bauer; Daniel Schmiedeke; Thomas Renné; Christoph Wanner; Jan Galle
Transmission of oxLDL-derived lipid peroxide radicals into membranes of vascular cells is the main inducer of oxLDL-mediated oxidative stress.
Atherosclerosis 2008;197(2):602-11.
2008: Lothar Schramm; Alexandra Seibold; Reinhard Schneider; Josef Zimmermann; Kai-Olaf Netzer; Christoph Wanner
Ischemic acute renal failure in the rat: effects of L-arginine and superoxide dismutase on renal function.
Journal of nephrology 2008;21(2):229-35.
2008: Frank Weidemann; Jörg Strotmann; Frank Breunig; Markus Niemann; R Maag; R Baron; Andreas O Eggert; Christoph Wanner
Misleading terms in Anderson-Fabry disease.
European journal of clinical investigation 2008;38(3):191-6.
2008: Frank Breunig; Christoph Wanner
Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
Journal of nephrology 2008;21(1):32-7.
2007: Frank Weidemann; Markus Niemann; Sebastian Herrmann; Margret Kung; Stefan Störk OR Stoerk; Christiane Waller; Meinrad Beer; Frank Breunig; Christoph Wanner; Wolfram Voelker; Georg Ertl; Bart Bijnens; Jörg Strotmann
A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium.
European heart journal 2007;28(24):3020-6.
2007: Susanne B Schwedler; Peter J Kuhlencordt; P Padmapriya Ponnuswamy; Gencay Hatiboglu; Thomas Quaschning; Julian Widder; Christoph Wanner; Lawrence Potempa; Jan Galle
Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species.
Atherosclerosis 2007;195(2):e76-84.
2007: Christoph Wanner
On statin treatment to prevent sepsis in dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;50(5):700-2.
2007: Vera Krane; Christoph Wanner
Dyslipidaemia in chronic kidney disease.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2007;59(3):299-316.
2007: Detlev Mönks; F Swoboda; Frank Breunig; Vera Krane; Christiane Drechsler; H Blum; Daniel Leising; Christoph Wanner
[Phenotyping of type 2 diabetes mellitus by "genetic field work": are data sufficient that are based only on a questionnaire?].
Deutsche medizinische Wochenschrift (1946) 2007;132(37):1875-9.
2007: Christoph Wanner; Frank Breunig
Fabry nephropathy and the case for adjunctive renal therapy.
Journal of the American Society of Nephrology : JASN 2007;18(9):2426-8.
2007: Thomas Quaschning; Florian Voss; Katharina Relle; Philipp Kalk; Nicolas Vignon-Zellweger; Thiemo Pfab; Christian Bauer; Franziska Theilig; Sebastian Bachmann; Annette Kraemer-Guth; Christoph Wanner; Franz Theuring; Jan Galle; Berthold Hocher
Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
Journal of the American Society of Nephrology : JASN 2007;18(3):730-40.
2007: Vera Krane; Detlef H Krieter; Manfred Olschewski; Winfried März; Johannes F E Mann; Eberhard Ritz; Christoph Wanner
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(2):267-75.
2007: Detlef H Krieter; Andreas Morgenroth; Artur Barasinski; Horst-Dieter Lemke; Oliver Schuster; Bodo von Harten; Christoph Wanner
Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(2):491-9.
2007: Jörg Strotmann; Frank Breunig; Christoph Wanner; Frank Weidemann
Progression of Fabry cardiomyopathy.
Clinical therapeutics 2007;29 Suppl A():S13-4.
2007: Kai Lopau; Alexandra Greser; Christoph Wanner
Efficacy and safety of preemptive anti-CMV therapy with valganciclovir after kidney transplantation.
Clinical transplantation 2007;21(1):80-5.
2007: Christoph Wanner; Christiane Drechsler; Vera Krane
Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2007;17(1):75-8.
2006: Vera Krane; Christiane Drechsler; Christoph Wanner
Dyslipidemia, inflammation and dialysis outcomes: what we know now.
Current opinion in nephrology and hypertension 2006;15(6):566-70.
2006: Meinrad Beer; Frank Weidemann; Frank Breunig; Anita Knoll; Sabrina Koeppe; Wolfram Machann; Dietbert Hahn; Christoph Wanner; Jörg Strotmann; Jörn Sandstede
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.
The American journal of cardiology 2006;97(10):1515-8.
2006: Susanne B Schwedler; Christoph Wanner
Should we reconsider the advanced glycation end product issue in hemodialysis patients?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;47(5):923; author reply 923-4.
2006: Vera Krane; Christoph Wanner
[Treatment of dyslipoproteinemia in chronic renal failure].
MMW Fortschritte der Medizin 2006;148(14):34-7.
2006: Vera Krane; Christoph Wanner
At which stage of chronic kidney disease should dyslipidemia be treated?
Nature clinical practice. Nephrology 2006;2(4):176-7.
2006: Frank Breunig; Frank Weidemann; Jörg Strotmann; Anita Knoll; Christoph Wanner
Clinical benefit of enzyme replacement therapy in Fabry disease.
Kidney international 2006;69(7):1216-21.
2006: Jan Galle; Thomas Hansen-Hagge; Christoph Wanner; Stefan Seibold
Impact of oxidized low density lipoprotein on vascular cells.
Atherosclerosis 2006;185(2):219-26.
2006: Andreas O Eggert; Rupert Wössner; Anita Knoll; Henning Hamm; Christoph Wanner; Frank Breunig
Umbilical angiectases as the sole clinical sign of Fabry disease in a 9-year-old boy.
European journal of pediatrics 2006;165(3):205-6.
2006: Susanne B Schwedler; János G Filep; Jan Galle; Christoph Wanner; Lawrence Potempa
C-reactive protein: a family of proteins to regulate cardiovascular function.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;47(2):212-22.
2006: Mario Berger; Hans H Stassen; Karola Köhler; Vera Krane; Detlev Mönks; Christoph Wanner; Katrin Hoffmann; Michael M Hoffmann; Michael Zimmer; Heike Bickeböller; Tom H Lindner
Hidden population substructures in an apparently homogeneous population bias association studies.
European journal of human genetics : EJHG 2006;14(2):236-44.
2006: Detlef H Krieter; Horst-Dieter Lemke; Christoph Wanner
Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(2):546; author reply 546.
2006: Thomas Quaschning; Berthold Hocher; Sabine Ruhl; Annette Kraemer-Guth; Johannes Tilgner; Christoph Wanner; Jan Galle
Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
Kidney & blood pressure research 2006;29(6):351-9.
2006: Kai Lopau; Katrin Spindler; Christoph Wanner
Effects of pravastatin treatment on blood pressure regulation after renal transplantation.
Kidney & blood pressure research 2006;29(6):329-37.
2005: Detlef H Krieter; Horst-Dieter Lemke; Bernard Canaud; Christoph Wanner
Beta(2)-microglobulin removal by extracorporeal renal replacement therapies.
Biochimica et biophysica acta 2005;1753(1):146-53.
2005: Jörg Strotmann; Frank Weidemann; Frank Breunig; Anita Knoll; Christoph Wanner; Georg Ertl
Morbus Fabry of the heart. Why should cardiologists care?
Zeitschrift für Kardiologie 2005;94(9):557-63.
2005: Susanne B Schwedler; Kerstin Amann; Konstanze Wernicke; Alexander Krebs; Markus Nauck; Christoph Wanner; Lawrence Potempa; Jan Galle
Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
Circulation 2005;112(7):1016-23.
2005: Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
The New England journal of medicine 2005;353(3):238-48.
2005: Lothar Schramm; T Weierich; E Heldbreder; Josef Zimmermann; Kai-Olaf Netzer; Christoph Wanner
Endotoxin-induced acute renal failure in rats: effects of L-arginine and nitric oxide synthase inhibition on renal function.
Journal of nephrology 2005;18(4):374-81.
2005: Gabi Schulgen; Manfred Olschewski; Vera Krane; Christoph Wanner; Günther Ruf; Martin Schumacher
Sample sizes for clinical trials with time-to-event endpoints and competing risks.
Contemporary clinical trials 2005;26(3):386-96.
2005: Frank Weidemann; Frank Breunig; Meinrad Beer; Jörn Sandstede; Stefan Störk OR Stoerk; Wolfram Voelker; Georg Ertl; Anita Knoll; Christoph Wanner; Jörg Strotmann
The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.
European heart journal 2005;26(12):1221-7.
2005: Thomas Quaschning; Benjamin Rebhan; Christoph Wunderlich; Christoph Wanner; Claus-Michael Richter; Thiemo Pfab; Christian Bauer; Annette Kraemer-Guth; Jan Galle; Masashi Yanagisawa; Berthold Hocher
Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading.
Journal of hypertension 2005;23(5):979-85.
2005: Mario Berger; Detlev Mönks; Henriette Schmidt; Vera Krane; Christoph Wanner; Ulrich Walter; Tom H Lindner
Are glucokinase mutations associated with low triglycerides?
Clinical chemistry 2005;51(4):791-3.
2005: Ulrike Raff; Reinhard Schneider; Stepan Gambaryan; Stefan Seibold; Mark Reber; Nicole Vornberger; Ralf Freund; Lothar Schramm; Christoph Wanner; Jan Galle
L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats.
Nephron. Physiology 2005;101(3):p39-50.
2004: Mario Berger; Silke Zschemisch; Berthold Hocher; Detlev Mönks; Torsten Slowinski; Horst Halle; Christoph Wanner; Ulrich Walter; Tom H Lindner
Alternative approach for rapid and reliable single-nucleotide polymorphism typing with double restriction mutagenesis primer PCR.
Clinical chemistry 2004;50(12):2376-8.
2004: Christoph Wanner; Udo Bahner; Renate Mattern; Dietmar Lang; Jutta Passlick-Deetjen
Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(10):2570-5.
2004: Lothar Schramm; Andreas Gal; Josef Zimmermann; Kai-Olaf Netzer; Ekkehart Heidbreder; Kai Lopau; Hermann Gröne; Christoph Wanner
Advanced renal insufficiency in a 34-year-old man with Lowe syndrome.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(3):538-43.
2004: Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Hans-Gernot Asmus; Walter Krämer; Karl-Wilhelm Kühn; Heinrich Kütemeyer; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics.
Kidney & blood pressure research 2004;27(4):259-66.
2003: Susanne B Schwedler; Frank Guderian; Jobst Dämmrich; Lawrence Potempa; Christoph Wanner
Tubular staining of modified C-reactive protein in diabetic chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(11):2300-7.
2003: Frank Weidemann; Frank Breunig; Meinrad Beer; Jörn Sandstede; Oliver Turschner; Wolfram Voelker; Georg Ertl; Anita Knoll; Christoph Wanner; Jörg Strotmann
Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study.
Circulation 2003;108(11):1299-301.
2003: Frank Breunig; Anita Knoll; Christoph Wanner
Enzyme replacement therapy in Fabry disease: clinical implications.
Current opinion in nephrology and hypertension 2003;12(5):491-5.
2003: Reinhard Schneider; Ulrike Raff; Nicole Vornberger; Monika Schmidt; Ralf Freund; Mark Reber; Lothar Schramm; Stepan Gambaryan; Christoph Wanner; Harald Schmidt; Jan Galle
L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats.
Kidney international 2003;64(1):216-25.
2003: Jan Galle; Alexander Mameghani; Steffen-Sebastian Bolz; Stepan Gambaryan; Maria Görg; Thomas Quaschning; Ulrike Raff; Holger Barth; Stefan Seibold; Christoph Wanner; Ulrich Pohl
Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA.
Journal of the American Society of Nephrology : JASN 2003;14(6):1471-9.
2003: Stefan Seibold; Claudia Rudroff; Manfred Weber; Jan Galle; Christoph Wanner; Martin Marx
Identification of a new tumor suppressor gene located at chromosome 8p21.3-22.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(9):1180-2.
2003: Tom H Lindner; Detlev Mönks; Christoph Wanner; Mario Berger
Genetic aspects of diabetic nephropathy.
Kidney international. Supplement 2003;(84):S186-91.
2003: Frank Breunig; Frank Weidemann; Meinrad Beer; Andreas O Eggert; Vera Krane; Matthias Spindler; Jörn Sandstede; Jörg Strotmann; Christoph Wanner
Fabry disease: diagnosis and treatment.
Kidney international. Supplement 2003;(84):S181-5.
2003: Thomas Quaschning; Jan Galle; Christoph Wanner
Vasopeptidase inhibition: a new treatment approach for endothelial dysfunction.
Kidney international. Supplement 2003;(84):S54-7.
2003: Jan Galle; Thomas Quaschning; Stefan Seibold; Christoph Wanner
Endothelial dysfunction and inflammation: what is the link?
Kidney international. Supplement 2003;(84):S45-9.
2003: Christoph Wanner; Vera Krane
Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S72-5.
2003: Mario Berger; Detlev Mönks; Christoph Wanner; Tom H Lindner
Diabetic nephropathy: an inherited disease or just a diabetic complication?
Kidney & blood pressure research 2003;26(3):143-54.
2003: Jan Galle; Stefan Seibold; Christoph Wanner
Inflammation in uremic patients: what is the link?
Kidney & blood pressure research 2003;26(2):65-75.
2003: Martin Zeier; Vedat Schwenger; Reinhold Deppisch; Ulrike Haug; Kai Weigel; Udo Bahner; Christoph Wanner; H Schneider; Thomas Henle; Eberhard Ritz
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
Kidney international 2003;63(1):298-305.
2002: Susanne B Schwedler; Thomas Metzger; Reinhard Schinzel; Christoph Wanner
Advanced glycation end products and mortality in hemodialysis patients.
Kidney international 2002;62(1):301-10.
2002: Christoph Wanner; Josef Zimmermann; Susanne B Schwedler; Thomas Metzger
Inflammation and cardiovascular risk in dialysis patients.
Kidney international. Supplement 2002;(80):99-102.
2002: Lothar Schramm; Mylinh La; Ekkehart Heidbreder; Markus Hecker; Joe S Beckman; Kai Lopau; Josef Zimmermann; Johann Rendl; Christoph Reiners; Sabine Winderl; Christoph Wanner; Harald Schmidt
L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation.
Kidney international 2002;61(4):1423-32.
2002: Christoph Wanner
Lipids in end-stage renal disease.
Journal of nephrology 2002;15(2):202-4.
2002: Vera Krane; Christoph Wanner
The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 11():23-7.
2002: Christoph Wanner; Vera Krane
Uremia-specific alterations in lipid metabolism.
Blood purification 2002;20(5):451-3.
2002: Christoph Wanner; Thomas Metzger
C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 8():29-32; discussion 39-40.
2002: Kai Lopau; Christoph Wanner
Progressive anorexia and chronic ascites after termination of CAPD.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(1):163-5.
2001: Christoph Wanner; Vera Krane; Thomas Metzger; Thomas Quaschning
Lipid changes and statins in chronic renal insufficiency and dialysis.
Journal of nephrology 2001;14 Suppl 4():S76-80.
2001: Thomas Quaschning; Vera Krane; Thomas Metzger; Christoph Wanner
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S14-9.
2001: Kai Lopau; L Hefner; G Bender; Ekkehart Heidbreder; Christoph Wanner
Haemodynamic effects of valsartan in acute renal ischaemia/reperfusion injury.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(8):1592-7.
2001: Christoph Wanner; Thomas Quaschning
Dyslipidemia and renal disease: pathogenesis and clinical consequences.
Current opinion in nephrology and hypertension 2001;10(2):195-201.
2001: K Heermeier; W Leicht; Alois Palmetshofer; Melanie Ullrich; Christoph Wanner; Jan Galle
Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cells.
Journal of the American Society of Nephrology : JASN 2001;12(3):456-63.
2001: Jan Galle; Alexandra N Heinloth; Christoph Wanner; K Heermeier
Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress.
Kidney international. Supplement 2001;78():S120-3.
2001: Susanne B Schwedler; Reinhard Schinzel; P Vaith; Christoph Wanner
Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?
Kidney international. Supplement 2001;78():S32-6.
2001: Christoph Wanner; Thomas Metzger; Vera Krane
Lipid lowering in end-stage renal disease.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2001;12(1):3-8.
2000: Alexandra N Heinloth; K Heermeier; Ulrike Raff; Christoph Wanner; Jan Galle
Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells.
Journal of the American Society of Nephrology : JASN 2000;11(10):1819-25.
2000: Jan Galle; C Lehmann-Bodem; U Hübner; Alexandra N Heinloth; Christoph Wanner
CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(3):339-46.
2000: Kai Lopau; D Kleinert; J Erler; Lothar Schramm; Ekkehart Heidbreder; Christoph Wanner
Tacrolimus in acute renal failure: does L-arginine-infusion prevent changes in renal hemodynamics?
Transplant international : official journal of the European Society for Organ Transplantation 2000;13(6):436-42.
2000: Kai Lopau; J Mark; Lothar Schramm; Ekkehart Heidbreder; Christoph Wanner
Hormonal changes in brain death and immune activation in the donor.
Transplant international : official journal of the European Society for Organ Transplantation 2000;13 Suppl 1():S282-5.
2000: Christoph Wanner
Importance of hyperlipidaemia and therapy in renal patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15 Suppl 5():92-6.
1999: K Heermeier; R Schneider; Alexandra N Heinloth; Christoph Wanner; S Dimmeler; Jan Galle
Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein(a).
Kidney international 1999;56(4):1310-2.
1999: Jan Galle; Christoph Wanner
Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation.
Mineral and electrolyte metabolism 1999;25(4-6):263-8.
1999: M Königer; Thomas Quaschning; Christoph Wanner; Peter Schollmeyer; Annette Krämer-Guth
Abnormalities in lipoprotein metabolism in hemodialysis patients.
Kidney international. Supplement 1999;71():S248-50.
1999: Thomas Quaschning; T Mainka; Markus Nauck; L C Rump; Christoph Wanner; Annette Krämer-Guth
Immunosuppression enhances atherogenicity of lipid profile after transplantation.
Kidney international. Supplement 1999;71():S235-7.
1999: Christoph Wanner; Vera Krane; Günther Ruf; Winfried März; Eberhard Ritz
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators.
Kidney international. Supplement 1999;71():S222-6.
1999: Jan Galle; K Heermeier; Christoph Wanner
Atherogenic lipoproteins, oxidative stress, and cell death.
Kidney international. Supplement 1999;71():S62-5.
1999: Jan Galle; U Zabel; U Hübner; A Hatzelmann; B Wagner; Christoph Wanner; Harald Schmidt
Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
British journal of pharmacology 1999;127(1):195-203.
1999: Jan Galle; R Schneider; Alexandra N Heinloth; Christoph Wanner; Peter Galle; E Conzelmann; S Dimmeler; K Heermeier
Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress.
Kidney international 1999;55(4):1450-61.
1999: Thomas Quaschning; M Schömig; M Keller; J Thiery; Markus Nauck; Peter Schollmeyer; Christoph Wanner; Annette Krämer-Guth
Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients.
Journal of the American Society of Nephrology : JASN 1999;10(2):332-41.
1998: Jan Galle; Beate Winner; E Conzelmann; Christoph Wanner
Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)].
Cellular and molecular biology (Noisy-le-Grand, France) 1998;44(7):1035-45.
1998: Stephan R Orth; A Stöckmann; C Conradt; Eberhard Ritz; M Ferro; W Kreusser; G Piccoli; M Rambausek; Dario Roccatello; K Schäfer; H G Sieberth; Christoph Wanner; B Watschinger; P Zucchelli
Smoking as a risk factor for end-stage renal failure in men with primary renal disease.
Kidney international 1998;54(3):926-31.
1998: P Kulzer; Christoph Wanner
Thrombotic microangiopathy: a challenge with uncertain outcome.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(8):2154-60.
1998: Jan Galle; R Schneider; Beate Winner; C Lehmann-Bodem; R Schinzel; Gerald Münch; E Conzelmann; Christoph Wanner
Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress.
Atherosclerosis 1998;138(1):65-77.
1998: Jan Galle; Christoph Wanner
Oxidized LDL and Lp(a). Preparation, modification, and analysis.
Methods in molecular biology (Clifton, N.J.) 1998;108():119-30.
1998: Christoph Wanner; J Zimmermann
Causes of coronary heart disease in patients on renal replacement therapy.
Kidney & blood pressure research 1998;21(2-4):287-9.
1997: Thomas Quaschning; M Königer; Annette Krämer-Guth; Stefan Greiber; Hermann Pavenstädt; Markus Nauck; Peter Schollmeyer; Christoph Wanner
Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(12):2528-36.
1997: Christoph Wanner; Stefan Greiber; Annette Krämer-Guth; Alexandra N Heinloth; Jan Galle
Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
Kidney international. Supplement 1997;63():S102-6.
1997: Christoph Wanner; J Zimmermann; Thomas Quaschning; Jan Galle
Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
Kidney international. Supplement 1997;62():S53-5.
1997: Annette Krämer-Guth; GL Busch; NK Kaba; S Schwedler; Christoph Wanner; Florian Lang
Effect of osmolarity on LDL binding and internalization in hepatocytes.
The American journal of physiology 1997;273(4 Pt 1):C1409-15.
1997: Annette Krämer-Guth; Thomas Quaschning; Hermann Pavenstädt; Jan Galle; Markus Nauck; Manfred W Baumstark; Peter Schollmeyer; Winfried März; Christoph Wanner
Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(7):1336-43.
1997: Stefan Greiber; M Kreusel; Hermann Pavenstädt; Peter Schollmeyer; Christoph Wanner
Lipoprotein(a) induces glomerular superoxide anion production.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(7):1330-5.
1997: W Bartens; Annette Krämer-Guth; Christoph Wanner
Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL)--but not of oxidized LDL and native or oxidized lipoprotein(a) [Lp(a)]--in HEPG2 cells: no evidence for Lp(a) catabolism via the LDL-receptor.
Metabolism: clinical and experimental 1997;46(7):726-9.
1997: Annette Krämer-Guth; Thomas Quaschning; Jan Galle; Manfred W Baumstark; M Königer; Markus Nauck; Peter Schollmeyer; Winfried März; Christoph Wanner
Structural and compositional modifications of diabetic low-density lipoproteins influence their receptor-mediated uptake by hepatocytes.
European journal of clinical investigation 1997;27(6):460-8.
1997: Josef Zimmermann; Lothar Schramm; E Mulzer; Ekkehart Heidbreder; H A Henrich; Christoph Wanner
[Cardiovascular risk factors in diabetic nephropathy].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(2):74-8.
1997: Stefan Greiber; Christoph Wanner
Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.
Mineral and electrolyte metabolism 1997;23(3-6):161-5.
1997: Stefan Greiber; Christoph Wanner
Effects of lipoprotein (a) on mesangial cell biology.
Contributions to nephrology 1997;120():146-52.
1997: Jan Galle; Alexandra N Heinloth; Susanne B Schwedler; Christoph Wanner
Effect of HDL and atherogenic lipoproteins on formation of O2- and renin release in juxtaglomerular cells.
Kidney international 1997;51(1):253-60.
1996: Markus Nauck; Annette Krämer-Guth; W Bartens; Winfried März; Heinrich Wieland; Christoph Wanner
Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients?
Clinical nephrology 1996;46(5):319-25.
1996: W Bartens; Markus Nauck; Christoph Wanner
[Combination antihypertensive therapy in patients with an increased risk profile].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(10):626-31.
1996: Annette Krämer-Guth; Thomas Quaschning; Stefan Greiber; Christoph Wanner
Potential role of lipids in the progression of diabetic nephropathy.
Clinical nephrology 1996;46(4):262-5.
1996: J Zimmermann; Lothar Schramm; Christoph Wanner; E Mulzer; H A Henrich; R Langer; Ekkehart Heidbreder
Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Clinical nephrology 1996;46(4):230-6.
1996: Lothar Schramm; Ekkehart Heidbreder; M Lukes; T Weierich; K Lopau; J Zimmermann; Christoph Wanner
Endotoxin-induced acute renal failure in the rat: effects of urodilatin and diltiazem on renal function.
Clinical nephrology 1996;46(2):117-24.
1996: Annette Krämer-Guth; Stefan Greiber; Hermann Pavenstädt; Thomas Quaschning; K Winkler; Peter Schollmeyer; Christoph Wanner
Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.
Kidney international 1996;49(5):1250-61.
1996: Stefan Greiber; Annette Krämer-Guth; Hermann Pavenstädt; M Gutenkunst; Peter Schollmeyer; Christoph Wanner
Effects of lipoprotein(a) on mesangial cell proliferation and viability.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(5):778-85.
1996: J Zimmermann; L Schramm; P Kulzer; M Korhammer; Christoph Wanner
[Risk of infection and wound healing disorders in dialysis patients].
Zentralblatt für Chirurgie 1996;121 Suppl():58-60.
1996: Annette Krämer-Guth; Markus Nauck; Thomas Quaschning; Hermann Pavenstädt; Heinrich Wieland; Peter Schollmeyer; Christoph Wanner
VLDL and LDL metabolism in human and rat mesangial cells.
Nephron 1996;74(2):378-85.
1996: J Galle; Christoph Wanner
Impact of nitric oxide on renal hemodynamics and glomerular function: modulation by atherogenic lipoproteins?
Kidney & blood pressure research 1996;19(1):2-15.
1996: Christoph Wanner; Annette Krämer-Guth; Markus Nauck; Thomas Quaschning; Hermann Pavenstädt; Peter Schollmeyer
Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
Mineral and electrolyte metabolism 1996;22(1-3):39-46.
1996: Christoph Wanner; W Bartens; Markus Nauck; Ingeborg Zäuner; Stefan Greiber; Peter Schollmeyer
Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
Mineral and electrolyte metabolism 1996;22(1-3):26-30.
1996: W Bartens; Markus Nauck; Peter Schollmeyer; Christoph Wanner
Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1996;16(1):27-33.
1995: Christoph Wanner; W Bartens; J Galle
Clinical utility of antilipidemic therapies in chronic renal allograft failure.
Kidney international. Supplement 1995;52():S60-2.
1995: Jan Galle; J Bengen; Peter Schollmeyer; Christoph Wanner
Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals.
Circulation 1995;92(6):1582-9.
1995: Stefan Greiber; M Gutenkunst; Christoph Wanner
[Atherogenic lipoprotein(a) as a progression factor in glomerular diseases: studies in cultured rat mesangial cells].
Immunität und Infektion 1995;23(2):50-2.
1995: M Späth; Hermann Pavenstädt; C Müller; J Petersen; Christoph Wanner; Peter Schollmeyer
Regulation of phosphoinositide hydrolysis and cytosolic free calcium induced by endothelin in human glomerular epithelial cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(8):1299-304.
1995: Wolfgang Grotz; Christoph Wanner; E Röther; Peter Schollmeyer
Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantation.
Nephron 1995;69(3):234-6.
1995: Jan Galle; P Stunz; Peter Schollmeyer; Christoph Wanner
Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells.
Kidney international 1995;47(1):45-52.
1995: Christoph Wanner; W Bartens; G Walz; Markus Nauck; Peter Schollmeyer
Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(1):75-81.
1995: Jan Galle; V B Schini; P Stunz; Christoph Wanner; Peter Schollmeyer
Interleukin-1 beta induces the formation of nitric oxide in isolated juxtaglomerular cells: influence on renin secretion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(2):191-7.
1994: Annette Krämer-Guth; Markus Nauck; Hermann Pavenstädt; M Königer; Heinrich Wieland; Peter Schollmeyer; Christoph Wanner
Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
Journal of the American Society of Nephrology : JASN 1994;5(4):1081-90.
1994: Jan Galle; M Ochslen; Peter Schollmeyer; Christoph Wanner
Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein.
Hypertension 1994;23(5):556-64.
1994: M M Späth; Hermann Pavenstädt; R Fischer; G Schlunck; Christoph Wanner; Peter Schollmeyer
Effects of histamine on inositol phosphates and intracellular Ca2+ in human glomerular epithelial cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(7):758-63.
1993: A Krämer; Markus Nauck; Hermann Pavenstädt; S Schwedler; Heinrich Wieland; Peter Schollmeyer; Christoph Wanner
Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells.
Kidney international 1993;44(6):1341-51.
1993: Jan Galle; Peter Schollmeyer; Christoph Wanner
Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium.
European heart journal 1993;14 Suppl I():111-7.
1993: Jan Galle; I Schenck; Peter Schollmeyer; Christoph Wanner
Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endothelium.
Hypertension 1993;21(3):315-21.
1992: Hermann Pavenstädt; M Späth; C Fiedler; R Fischer; G Schlunck; Christoph Wanner; Peter Schollmeyer
Effect of bradykinin on the cytosolic free calcium activity and phosphoinositol turnover in human glomerular epithelial cells.
Renal physiology and biochemistry 1992;15(6):277-88.
1992: Hermann Pavenstädt; M Späth; G Schlunck; Markus Nauck; R Fischer; Christoph Wanner; Peter Schollmeyer
Effect of nucleotides on the cytosolic free calcium activity and inositol phosphate formation in human glomerular epithelial cells.
British journal of pharmacology 1992;107(1):189-95.
1992: Christoph Wanner; I Lubrich-Birkner; O Summ; H Wieland; Peter Schollmeyer
Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients.
Nephron 1992;62(1):40-6.
1991: Wolfgang Grotz; Christoph Wanner; E Keller; Joachim Böhler; H H Peter; R Rohrbach; Peter Schollmeyer
Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.
Clinical nephrology 1991;35(6):243-51.
1991: Christoph Wanner; W H Hörl; C H Luley; H Wieland
Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis.
Kidney international 1991;39(4):754-60.
1991: M M Späth; Hermann Pavenstädt; T Kirste; J Pfeilschifter; Christoph Wanner; Peter Schollmeyer
Effect of cell density on growth regulation of human glomerular epithelial cells. Inhibition of growth by dbcAMP and cAMP-elevating agonists.
Cellular signalling 1991;3(5):405-11.
1990: K W Dreyling; Christoph Wanner; Peter Schollmeyer
Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
Clinical nephrology 1990;33(4):179-83.
1990: Christoph Wanner; B Wäckerle; H Boeckle; Peter Schollmeyer; Walter H Hörl
Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients.
The American journal of clinical nutrition 1990;51(3):407-10.
1990: Christoph Wanner; H Wieland; Markus Nauck; G Schaeffer; Peter Schollmeyer; Walter H Hörl
Effective hypolipidaemic therapy with beclobrate in haemodialysis patients: interference with L-carnitine.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(8):588-93.
1989: Christoph Wanner; Heinrich Wieland; B Wäckerle; H Boeckle; Peter Schollmeyer; Walter H Hörl
Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
Kidney international. Supplement 1989;27():S264-8.
1989: Walter H Hörl; W Riegel; Christoph Wanner; M Haag-Weber; Peter Schollmeyer; H Wieland; H Wilms
Endocrine and metabolic abnormalities following kidney transplantation.
Klinische Wochenschrift 1989;67(17):907-18.
1989: Walter H Hörl; Christoph Wanner; Peter Schollmeyer; Roland M Schaefer; August Heidland
Long-term outcome in diabetic patients on hemodialysis treatment.
Contributions to nephrology 1989;73():163-9.
1989: Walter H Hörl; Christoph Wanner; W Riegel; W Schlosser; H Wilms; Peter Schollmeyer
Reduction of degranulation of polymorphonuclear leukocytes by immunosuppression in patients following cadaveric renal transplantation.
Transplantation 1989;47(1):144-8.
1989: Christoph Wanner; W Riegel; R M Schaefer; W H Hörl
Carnitine and carnitine esters in acute renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1989;4(11):951-6.
1989: Walter H Hörl; Roland M Schaefer; Christoph Wanner; J Bahlmann; J Reitinger; Peter Schollmeyer; August Heidland
Enhanced plasma and intracellular levels of main granulocyte components in diabetics on dialysis.
Blood purification 1989;7(6):314-23.
1988: Christoph Wanner; Peter Schollmeyer; Walter H Hörl
Serum carnitine levels and carnitine esters of patients after kidney transplantation: role of immunosuppression.
Metabolism: clinical and experimental 1988;37(3):263-7.
1988: Christoph Wanner; Stefan Greiber; G Kirste; Peter Schollmeyer; Walter H Hörl
Urinary proteinase activity in patients with acute renal failure after trauma and kidney transplantation.
Advances in experimental medicine and biology 1988;240():309-14.
1988: Christoph Wanner; Walter H Hörl
Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects.
Nephron 1988;50(2):89-102.
1988: Christoph Wanner; B Simon; A Gösele; W Riegel; Peter Schollmeyer; Walter H Hörl
Effect of immunosuppression on the release of main granulocyte components: in vivo and in vitro studies.
Advances in experimental medicine and biology 1988;240():385-9.
1988: Walter H Hörl; Christoph Wanner; Peter Schollmeyer; M Ogawa
Plasma levels of pancreatic secretory trypsin inhibitor in relation to amylase and lipase in patients with acute and chronic renal failure.
Nephron 1988;49(1):33-8.
1987: Christoph Wanner; S Förstner-Wanner; C Rössle; P Fürst; Peter Schollmeyer; Walter H Hörl
Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
Kidney international. Supplement 1987;22():S132-5.
1987: Walter H Hörl; W Riegel; H B Steinhauer; Christoph Wanner; Peter Schollmeyer; Roland M Schaefer; August Heidland
Plasma levels of main granulocyte components during hemodialysis.
Contributions to nephrology 1987;59():35-43.
1986: Walter H Hörl; W Riegel; H B Steinhauer; Christoph Wanner; F Thaiss; F Bozkurt; M Haag; Peter Schollmeyer
Granulocyte activation during hemodialysis.
Clinical nephrology 1986;26 Suppl 1():S30-4.